The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of circulating tumor DNA (ctDNA) testing in patients (pts) with rectal cancer after neoadjuvant therapy (NAT) and surgery.
 
Sakti Chakrabarti
Honoraria - BioMedical Insights; Cancer Expert Now; HalioDx; Histosonics; Natera; omnihealth Media; QED Therapeutics
Speakers' Bureau - Bristol Myers Squibb; Merck; Natera; Seagen
(OPTIONAL) Uncompensated Relationships - Binacea
 
Stacey A. Cohen
Consulting or Advisory Role - Bayer; Delcath Systems; Eisai; Pfizer; Regeneron; Taiho Oncology
Research Funding - Biomea (Inst); BioNTech SE (Inst); Natera; Pfizer (Inst); Tempus (Inst)
Expert Testimony - Evans, Craven & Lackie
Travel, Accommodations, Expenses - Biomea Fusion; Natera
 
Antony Tin
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Autumn Dangl
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Vasily N. Aushev
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Mohamedtaki Abdulaziz Tejani
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Natera
Research Funding - Bayer (Inst)
 
Sreenivasa R Chandana
Speakers' Bureau - Natera
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BMS (Inst); Elevation Oncology (Inst); Exact Sciences (Inst); Macrogenics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Zymeworks (Inst)
 
Midhun Malla
Consulting or Advisory Role - AstraZeneca; Exelixis; Natera
 
Ron G. Landmann
Honoraria - Natera
Consulting or Advisory Role - Ethicon/Johnson & Johnson
Research Funding - Intuitive Surgical (Inst)
Travel, Accommodations, Expenses - Ethicon/Johnson & Johnson; Natera
 
Vivek R. Sharma
Stock and Other Ownership Interests - Madrigal Pharmaceuticals
Honoraria - Alexion Pharmaceuticals; Biomarin; Genzyme; Kedrion Biopharma; Novo Nordisk; Takeda
Consulting or Advisory Role - FORMA Therapeutics; HEMA Biologics
Speakers' Bureau - Alexion Pharmaceuticals; Biomarin; Genzyme; Novo Nordisk
 
Gregory P. Botta
Honoraria - Natera
Consulting or Advisory Role - Natera
Speakers' Bureau - Natera
 
Arun Nagarajan
No Relationships to Disclose
 
Georges Azzi
Stock and Other Ownership Interests - Aptose Biosciences; Cellectis; CohBar; CytomX Therapeutics; CytomX Therapeutics; FibroGen; Global Blood Therapeutics; Guardant Health; Halozyme; Illumina; InVitae; Sangamo Therapeutics; TG Therapeutics; Zymeworks
Honoraria - Abbvie; Blueprint Medicines; Bristol-Myers Squibb; Exelixis; Gilead Sciences (Inst); Pfizer
Speakers' Bureau - Guardant Health; Natera
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Mirati Therapeutics (Inst); Natera (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Exelixis; Exelixis; Mirati Therapeutics
 
May Thet Cho
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Basilea; Eisai; Exelixis; Genentech/Roche; Ipsen; QED Therapeutics; Seagen; Taiho Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Daiichi Sankyo/Astra Zeneca; Helsinn Therapeutics; natera; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); incyte (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Farshid Dayyani
Employment - Roche (I)
Consulting or Advisory Role - Array BioPharma; Eisai; Exelixis; Genentech/Roche; QED Therapeutics; Signatera
Speakers' Bureau - Amgen; Deciphera; Eisai; Exelixis; Genentech/Roche; ipsen; Natera; SERVIER; Sirtex Medical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech (Inst); Ipsen (Inst); Merck (Inst); Taiho Pharmaceutical (Inst)
 
Diana L. Hanna
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim
Research Funding - Agenus (Inst); Dragonfly Therapeutics (Inst); Indaptus Therapeutics (Inst); Toray Industries (Inst); Xilio Therapeutics (Inst)
 
Adham A Jurdi
Employment - Natera
Stock and Other Ownership Interests - Cardiff Oncology; natera
Speakers' Bureau - Natera
Travel, Accommodations, Expenses - Natera
 
Minetta C. Liu
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Eisai (Inst); Exact Sciences (Inst); Genomic Health (Inst); GRAIL (Inst); Menarini Silicon Biosystems (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Genomic Health; GRAIL; Menarini Silicon Biosystems; Merck; Natera; Pfizer
 
Arvind Dasari
Consulting or Advisory Role - HutcMed; Illumina/GRAIL; Personalis; SIRTIS; Takeda
Research Funding - Eisai (Inst); Guardant Health (Inst); Hutchison MediPharma (Inst); Merck (Inst); Natera (Inst); XENCOR (Inst)
Travel, Accommodations, Expenses - Hutchison MediPharma; Takeda
 
Pashtoon Murtaza Kasi
Leadership - Precision Biosensors
Stock and Other Ownership Interests - Elicio Therapeutics
Consulting or Advisory Role - Bayer; BostonGene; BostonGene; Daiichi Sankyo/Astra Zeneca; Delcath Systems; Eisai; Elicio Therapeutics; Exact Sciences; Foundation Medicine; Guardant Health; Illumina; Ipsen (Inst); Lilly; MSD Oncology; Natera; NeoGenomics Laboratories; QED Therapeutics; SAGA Diagnostics; Seagen; SERVIER; Taiho Oncology; Taiho Pharmaceutical (Inst); Tempus
Research Funding - Advanced Accelerator Applications (Inst); Boston Scientific (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca